{{Rsnum
|rsid=2075533
|Gene=TNFSF8
|Chromosome=9
|position=114931351
|Orientation=minus
|GMAF=0.4348
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=TNFSF8
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 37.2 | 46.0 | 16.8
| HCB | 30.7 | 53.3 | 16.1
| JPT | 20.4 | 48.7 | 31.0
| YRI | 0.7 | 20.4 | 78.9
| ASW | 5.3 | 33.3 | 61.4
| CHB | 30.7 | 53.3 | 16.1
| CHD | 36.7 | 47.7 | 15.6
| GIH | 40.6 | 42.6 | 16.8
| LWK | 1.8 | 21.8 | 76.4
| MEX | 12.1 | 36.2 | 51.7
| MKK | 5.8 | 30.1 | 64.1
| TSI | 30.4 | 52.9 | 16.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=21292647
|Title=Association of a novel functional promoter variant (rs2075533 C&gt;T) in the apoptosis gene TNFSF8 with risk of lung cancer - a finding from Texas lung cancer genome-wide association study
|OA=1
}}

{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}